HK Stock Market Move | ZJLD (06979) fell more than 4% to hit a new low. Overall sales of Mid-Autumn Festival white spirits are weak. Institutions say there is pressure on sales in various regions.
Rare Wine Lee (06979) fell over 4%, hitting a low of 5.68 Hong Kong dollars during trading hours, setting a new low since listing. As of the time of writing, it has fallen by 4.01% to 5.75 Hong Kong dollars, with a turnover of 19.9462 million Hong Kong dollars.
ZJLD (06979) fell more than 4%, hitting a low of 5.68 Hong Kong dollars during trading, setting a new low for the listing. As of the time of writing, it is down 4.01% to 5.75 Hong Kong dollars, with a trading volume of 19.9462 million Hong Kong dollars.
On the news front, overall sales of Baijiu during the Mid-Autumn Festival this year have been weak. According to industry norms, sales of Baijiu during the Mid-Autumn and National Day holidays typically account for 20% to 30% of a distillery's annual sales. However, several liquor merchants have recently reported that sales of Baijiu during the Mid-Autumn Festival this year have not met expectations. An official from the Sichuan Liquor Distribution Association revealed that sales during this Mid-Autumn Festival are expected to decrease by 20% to 30% compared to last year.
Data from Guotai Junan Securities shows that Baijiu industry sales in August and September have slightly improved compared to the previous month, but overall demand in most regions has still declined year-on-year, with price pressure greater than sales pressure. Guosen also stated that as the Mid-Autumn Festival approaches, channel stocking enthusiasm is low and the consumer atmosphere is weaker than last year, with consumers being more rational. In terms of price range, mid-range Baijiu is selling better than mid to high-end Baijiu. In terms of regions, sales pressure is evident everywhere.
 Related Articles 

HK Stock Market Move  | BOAN BIOTECH (06955) surged more than 4%, and the enrollment of all patients in the Chinese Phase III clinical trial of Navulimab monoclonal antibody is complete.

HK Stock Market Move  | ASCLETIS-B(01672) now up more than 4%. Subcutaneous injection of the glucagon-like peptide-1 receptor agonist ASC36 has entered the clinical development stage.

HK Stock Market Move  | ZOOMLION (01157) rose more than 4% after the performance results. The net profit attributable to the parent company increased by 24.89% year-on-year in the first three quarters. The company continues to expand its mining machinery business.
HK Stock Market Move  | BOAN BIOTECH (06955) surged more than 4%, and the enrollment of all patients in the Chinese Phase III clinical trial of Navulimab monoclonal antibody is complete.

HK Stock Market Move  | ASCLETIS-B(01672) now up more than 4%. Subcutaneous injection of the glucagon-like peptide-1 receptor agonist ASC36 has entered the clinical development stage.

HK Stock Market Move  | ZOOMLION (01157) rose more than 4% after the performance results. The net profit attributable to the parent company increased by 24.89% year-on-year in the first three quarters. The company continues to expand its mining machinery business.

RECOMMEND

First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025

Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025

Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025


